当前位置:产品中心>单抗/多抗

Research Grade Inbakicept|Inbakicept(研究用级别)(靶标:Inbakicept融合蛋白)

货号:RB9T37016013
  • 价格:面议
  • 点击数:431
  

产品介绍

产品参数

形态Liquid
抗体亚型Fusion - [IL15RA (interleukin 15 receptor subunit
纯度>95% purity as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
浓度1mg/ml
内毒素水平Please contact the lab for this information.
应用ELISA, Functional assay, Research in vivo
种属反应性Human
靶标IL15, IL-15, Interleukin-15
储存缓冲液0.01M PBS, pH 7.4.
稳定性和储存Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
表达系统Mammalian Cells
登录号P40933
背景信息Inbakicept is a dimeric human IL-15 receptor alpha (IL-15 Ra) sushi domain/human IgG1 Fc fusion protein and is an IL-15 superagonist complex. Inbakicept is able to form complex N-803 (Nogapendekin alfa inbakicept) with the IL-15 antibody Nogapendekin alfa in a 1:2 ratio. N-803 mimics the function of IL-15 and amplifies anti-CD20 mAb-mediated NK cell responses and antibody-dependent cellular cytotoxicity (ADCC). N-803 also increases degranulation and IFNγ production in cells.<br>• Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer., PMID:35660135<br/>• Interleukin 15: A key cytokine for immunotherapy., PMID:27325459<br/>• IL-15 in the Combination Immunotherapy of Cancer., PMID:32508818<br/>• IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells., PMID:31277710<br/>• Interleukin-15 in autoimmunity., PMID:32919253<br/>• Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers., PMID:39604730<br/>• An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis delivery., PMID:36165896<br/>• IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease., PMID:32051586<br/>• Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect <i>in vivo</i>., PMID:37818365<br/>• Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy., PMID:34797911<br/>
别名ALT-803(=inbakiceptINN11029([IL15RA]2-Fc)incomplex1:2withnogapendekinalfaINN11157(IL15D72)), [IL15RA]2-Fc, 2135939-52-3
备注For research use only. Not suitable for clinical or therapeutic use.